News from alimera sciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:ALIM)

Jan 04, 2016, 07:30 ET

Alimera Sciences Announces ILUVIEN® J Code J7313 Is Now Active

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Dec 15, 2015, 07:30 ET

Alimera Sciences Signs Agreement To Distribute ILUVIEN® In The Middle East

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 16, 2015, 07:30 ET

Alimera Sciences Announces New 36-Month Analysis That Shows ILUVIEN® Slows Diabetic Retinopathy Progression

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 09, 2015, 07:30 ET

Alimera Sciences To Speak At Ophthalmology Innovation Summit 2015

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 05, 2015, 16:19 ET

Alimera Sciences Reports Third Quarter 2015 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 04, 2015, 07:30 ET

Alimera Sciences announces late breaking presentation of new ILUVIEN® Analysis During Retina Subspecialty day at AAO annual meeting 2015

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Nov 03, 2015, 08:30 ET

Alimera Sciences Strengthens Financial Position

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Oct 29, 2015, 08:30 ET

Alimera Sciences To Release Third Quarter Fiscal Year 2015 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Sep 28, 2015, 07:30 ET

Alimera Sciences Limited Announces Availability Of Review Paper On Real World Experience With ILUVIEN®

 Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that...

Sep 24, 2015, 07:30 ET

Alimera Sciences Limited Announces ILUVIEN® Study Results Presented At 15th Euretina Congress

Alimera Sciences, Inc., (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Aug 13, 2015, 08:00 ET

Alimera Sciences Limited Signs Exclusive ILUVIEN® Distributor for Italy, San Marino and Vatican City

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Aug 10, 2015, 16:06 ET

Alimera Sciences Reports Second Quarter 2015 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Jul 30, 2015, 08:30 ET

Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Jul 21, 2015, 07:30 ET

Alimera Sciences Signs Knight Therapeutics As Exclusive ILUVIEN® Distributor For Canada

Alimera Sciences, Inc. (NASDAQ: ALIM) ("Alimera"), a pharmaceutical company that specializes in the research, development and...

Jun 29, 2015, 16:05 ET

Alimera Sciences To Present At Cantor Fitzgerald Inaugural Healthcare Conference

 Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

May 18, 2015, 16:22 ET

Alimera Sciences Announces Presentation Time Change At UBS Global Healthcare Conference

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

May 11, 2015, 07:30 ET

Alimera Sciences To Present At UBS Global Healthcare Conference

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

May 07, 2015, 16:05 ET

Alimera Sciences Reports First Quarter 2015 Financial Results

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...

Apr 28, 2015, 16:05 ET

Alimera Sciences to Release First Quarter 2015 Financial Results

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization...

Apr 21, 2015, 17:10 ET
http://www.multivu.com/players/English/7496251-iluvien-dme/gallery/image/2535f9d6-85db-4380-9b62-e598697ec47d.HR.jpg

ILUVIEN® Is Now Widely Available To Diabetic Macular Edema Patients Throughout The U.S.

Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of...